4.02
-0.02(-0.50%)
Currency In USD
| Previous Close | 4.04 |
| Open | 4.04 |
| Day High | 4.2 |
| Day Low | 3.82 |
| 52-Week High | 11.2 |
| 52-Week Low | 2.92 |
| Volume | 57,110 |
| Average Volume | 60,587 |
| Market Cap | 25.94M |
| PE | -0.55 |
| EPS | -7.36 |
| Moving Average 50 Days | 3.76 |
| Moving Average 200 Days | 5.93 |
| Change | -0.02 |
If you invested $1000 in Kala Pharmaceuticals, Inc. (KALA) since IPO date, it would be worth $4.35 as of June 24, 2025 at a share price of $4.02. Whereas If you bought $1000 worth of Kala Pharmaceuticals, Inc. (KALA) shares 5 years ago, it would be worth $7.14 as of June 24, 2025 at a share price of $4.02.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
KALA BIO to Present at Jefferies Global Healthcare Conference
GlobeNewswire Inc.
May 29, 2025 12:00 PM GMT
ARLINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
GlobeNewswire Inc.
Feb 26, 2025 1:00 PM GMT
ARLINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the ey
KALA BIO Announces Chief Executive Officer Transition
GlobeNewswire Inc.
Feb 12, 2025 1:00 PM GMT
ARLINGTON, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the ey